Moberg Pharma AB (publ) (STO:MOB)

Chimerix Revenue

Moberg Pharma AB had revenue of 3.87M SEK in the quarter ending March 31, 2025, with 371.83% growth. This brings the company's revenue in the last twelve months to 12.86M, up 1,468.29% year-over-year. In the year 2024, Moberg Pharma AB had annual revenue of 9.81M.

• Revenue (ttm): 12.86M
• Revenue Growth: +1,468.29%
• P/S Ratio: 32.93
• Revenue / Employee: 1.43M
• Employees: 10
• Market Cap: 423.48M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	9.81M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	207.00K	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	33.66M	-16.83M	-33.33%